Clinical trial
Phase 3
Interventional
Ages 18 to 85
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
Run by Praxis Precision Medicines · NCT07287163 · Data updated 2026-11-12
Enrolling by invitation only. This study is not taking new participants. Its registered completion date is 2028-05-31.
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 700 (estimated) |
| Sponsor | Praxis Precision Medicines Industry-sponsored |
| Drugs / interventions | vormatrogine |
| Locations | 36 sites (Brazil, Germany, Italy, Poland, Spain, United States) |
| Trial ID | NCT07287163 on ClinicalTrials.gov |
What this trial studies
An open label extension clinical trial to assess the safety and tolerability of vormatrigine in adults with focal or primary generalized tonic-clonic seizures.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant who completed an eligible clinical trial (unless agreed by the sponsor medical monitor), including PRAX-628-212, PRAX-628-321 or other vormatrigine trials, or participant who has received vormatrigine outside of an eligible clinical trial (such as an expanded access program) * Participant who had adequate seizure diary and vormatrigine adherence and had been otherwise adherent to the study procedures in the opinion of the investigator unless deemed unacceptable by sponsor Exclusion Criteria: * Participant who withdrew or discontinued treatment from the treatment period of an eligible clinical trial unless deemed acceptable by the sponsor * Participant who plans to enter another interventional investigational study or is on any prohibited medication * Participant who is pregnant, lactating or planning to become pregnant * Participant who is ineligible for the extension clinical trial in the view of the investigator
Where it's running
-
Praxis Research Site
Miami, Florida, United States -
Praxis Research Site
Miami Lakes, Florida, United States -
Praxis Research Site
Naples, Florida, United States -
Praxis Research Site
Lafayette, Louisiana, United States -
Praxis Research Site
Bethesda, Maryland, United States -
Praxis Research Site
Plymouth, Michigan, United States
Show 30 more locations
-
Praxis Research Site
Chesterfield, Missouri, United States -
Praxis Research Site
Hackensack, New Jersey, United States -
Praxis Research Site
Amherst, New York, United States -
Praxis Research Site
Middletown, New York, United States -
Praxis Research Site
New York, New York, United States -
Praxis Research Site
Niagara Falls, New York, United States -
Praxis Research Site
Philadelphia, Pennsylvania, United States -
Praxis Research Site
El Paso, Texas, United States -
Praxis Research Site
Houston, Texas, United States -
Praxis Research Site
Porto Alegre, Rio Grande do Sul, Brazil -
Praxis Research Site
São José do Rio Preto, São Paulo, Brazil -
Praxis Research Site
Bielefeld, Germany -
Praxis Research Site
Tübingen, Germany -
Praxis Research Site
Pozzilli, Isernia, Italy -
Praxis Research Site
Bosisio Parini, Lecco, Italy -
Praxis Research Site
Milan, Italy -
Praxis Research Site
Naples, Italy -
Praxis Research Site
Pavia, Italy -
Praxis Research Site
Pisa, Italy -
Praxis Research Site
Ponderano, Italy -
Praxis Research Site
Roma, Italy -
Praxis Research Site
Bydgoszcz, Poland -
Praxis Research Site
Katowice, Poland -
Praxis Research Site
Lublin, Poland -
Praxis Research Site
Warsaw, Poland -
Praxis Research Site
Barcelona, Spain -
Praxis Research Site
Madrid, Spain -
Praxis Research Site
Málaga, Spain -
Praxis Research Site
Terrassa, Spain -
Praxis Research Site
Valencia, Spain
Study contacts
- Principal investigator: Medical Director — Praxis Precision Medicines
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-16 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.